“ab fubinaca”的搜索结果

产品 51 到 100 共 366个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置降序顺序
  1. CID-1067700

    Catalog No. A21560
    Quick View
    pan GTPase inhibitor
    CID-1067700 (ML282) is a pan GTPase inhibitor, and competitively inhibits Ras-related in brain 7 (Rab7) with a Ki of 13 nM. 了解更多
  2. MK-0674

    Catalog No. A21558
    Quick View
    cathepsin K inhibitor
    MK-0674 is a potent, orally bioavailable and selective cathepsin K inhibitor, with an IC50 of 0.4 nM, shows 1156, 1465, 11857 and 243 fold selectivity over Cat B, Cat F, Cat L and Cat S. 了解更多
  3. Eniluracil

    Catalog No. A21548
    Quick View
    dihydropyrimidine dehydrogenase inhibitor
    Eniluracil (5-Ethynyluracil), a uracil analogue and a mechanism-based irreversible inhibitor of dihydropyrimidine dehydrogenase (DPD), increases the oral bioavailability of 5-fluorouracil (5-FU) to 100%, facilitating uniform absorption and predictable toxicity. 了解更多
  4. Genz-123346

    Catalog No. A21536
    Quick View
    glucosylceramide synthase inhibitor
    Genz-123346 is a potent, orally available glucosylceramide synthase inhibitor. 了解更多
  5. Beclabuvir

    Catalog No. A21511
    Quick View
    HCV NS5B RNA-dependent RNA polymerase inhibitor
    Beclabuvir is an allosteric inhibitor that binds to thumb site 1 of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, and inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 with IC50 of < 28 nM. 了解更多
  6. Amuvatinib hydrochloride

    Catalog No. A21503
    Quick View
    multi-targeted tyrosine kinase inhibitor
    Amuvatinib hydrochloride (MP470 hydrochloride) is an orally bioavailable multi-targeted tyrosine kinase inhibitor with potent activity against mutant c-Kit, PDGFRα, Flt3, c-Met and c-Ret. 了解更多
  7. AS601245

    Catalog No. A21502
    Quick View
    cell-permeable JNK Inhibitor
    AS601245 is a cell-permeable JNK Inhibitor with IC50s of 150, 220, and 70 nM for three JNK human isoforms (hJNK1, hJNK2, and hJNK3), respectively. 了解更多
  8. Sorafenib (D4)

    Catalog No. A21495
    Quick View
    multikinase inhibitor
    Sorafenib D4 (Bay 43-9006 D4) is the deuterium labeled Sorafenib. Sorafenib is a multikinase inhibitor IC50s of 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively. 了解更多
  9. Sorafenib (D3)

    Catalog No. A21489
    Quick View
    multikinase inhibitor
    Sorafenib D3 (Bay 43-9006 D3) is the deuterium labeled Sorafenib. Sorafenib is a multikinase inhibitor IC50s of 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively. 了解更多
  10. Y15

    Catalog No. A21472
    Quick View
    FAK inhibitor
    Y15 is a potent and specific inhibitor of focal adhesion kinase (FAK) that inhibits its autophosphorylation activity, decreases the viability of cancer cells, and blocks tumor growth. 了解更多
  11. (R)-Rivastigmine D6 tartrate

    Catalog No. A21454
    Quick View
    cholinesterase inhibitor
    (R)-Rivastigmine D6 (tartrate) is the deuterium labeled (R)-Rivastigmine, which is an cholinesterase inhibitor. 了解更多
  12. (-)-Talarozole

    Catalog No. A21451
    Quick View
    retinoic acid metabolism inhibitor
    (-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. 了解更多
  13. Trametinib (DMSO solvate)

    Catalog No. A21450
    Quick View
    MEK inhibitor
    Trametinib DMSO solvate (GSK-1120212 (DMSO solvate);JTP-74057 (DMSO solvate)) is a potent MEK inhibitor that specifically inhibits MEK1/2, with an IC50 value of about 2 nM. 了解更多
  14. CVT-12012

    Catalog No. A21447
    Quick View
    SCD inhibitor
    CVT-12012 is a potent and orally bioavailable stearoyl-coA desaturase (SCD) inhibitor, with IC50s of 38 nM, 6.1 nM for rat microsomal and human HEPG2, respectively. 了解更多
  15. (+)-Talarozole

    Catalog No. A21445
    Quick View
    retinoic acid metabolism inhibitor
    (+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. 了解更多
  16. Raphin1 acetate

    Catalog No. A21373
    Quick View
    PPP1R15B inhibitor
    Raphin1 acetate is an orally bioavailable, selective inhibitor of the regulatory phosphatase PPP1R15B (R15B). 了解更多
  17. Rasagiline 13C3 mesylate racemic

    Catalog No. A21350
    Quick View
    Monoamine oxidase inhibitor
    Rasagiline 13C3 mesylate racemic is the deuterium labeled Rasagiline, which is an irreversible inhibitor of monoamine oxidase. 了解更多
  18. Lazabemide

    Catalog No. A21270
    Quick View
    MAO-B inhibitor
    Lazabemide(Ro 19-6327) is selective, reversible monoamine oxidase B (MAO-B) inhibitor (IC50 values are 0.03 and > 100 μM for MAO-B and MAO-A respectively). 了解更多
  19. Lapaquistat

    Catalog No. A21262
    Quick View
    cholesterol biosynthesis inhibitor
    Lapaquistat (T-91485), a cholesterol biosynthesis inhibitor, is the active metabolite of TAK-475. Lapaquistat can decrease statin-induced myotoxicity in lipid-lowering therapy. 了解更多
  20. Rosabulin

    Catalog No. A21254
    Quick View
    microtubule inhibitor
    Rosabulin is a potent microtubule inhibitor, with anti-cancer activities. 了解更多
  21. HDAC-IN-7

    Catalog No. A21252
    Quick View
    HDAC1/2/3/10 inhibitor
    HDAC-IN-7 (Chidamide impurity) is an impurity of Chidamide. Chidamide is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor. 了解更多
  22. Indibulin

    Catalog No. A21210
    Quick View
    Tubulin assembly
    Indibulin (ZIO 301), an orally applicable inhibitor of tubulin assembly, shows potent anticancer activity with a minimal neurotoxicity. 了解更多
  23. MDR-1339

    Catalog No. A21138
    Quick View
    Aβ-aggregation inhibitor
    MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease. 了解更多
  24. Risarestat

    Catalog No. A21112
    Quick View
    aldose reductase inhibitor
    Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications 了解更多
  25. CCT241736

    Catalog No. A21097
    Quick View
    dual FLT3/Aurora kinase inhibitor
    CCT241736 is a potent and orally bioavailable dual FLT3 and Aurora kinase inhibitor. 了解更多
  26. MUT056399

    Catalog No. A21084
    Quick View
    FabI enzyme inhibitor
    MUT056399 (Fab-001) is a highly potent inhibitor of the FabI enzyme of both S. aureus and E. coli with 50% inhibitory concentration IC50s of 12 nM and 58 nM, respectively. 了解更多
  27. Ibiglustat

    Catalog No. A21083
    Quick View
    GCS inhibitor
    Ibiglustat (Venglustat), a potential therapy for PD Parkinson??s disease, SRT in Fabry??s and Gaucher??s, is a selective, allosteric inhibitor of glucosylceramide synthase (GCS) with ability to cross the blood-brain barrier. 了解更多
  28. Relebactam

    Catalog No. A21071
    Quick View
    diazabicyclooctane inhibitor
    Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes. 了解更多
  29. Galidesivir hydrochloride

    Catalog No. A20930
    Quick View
    RdRp inhibitor
    Galidesivir hydrochloride (BCX 4430 hydrochloride) is a viral RNA-dependent RNA polymerase (RdRp) inhibitor; demonstrated broad-spectrum activity in multiple viruses and a favorable preliminary preclinical safety profile. 了解更多
  30. EL-102

    Catalog No. A20925
    Quick View
    HIF1α inhibitor
    EL102 is a inhibitor of HIF1α , Which can inhibit tubulin polymerisation and decreased microtubule stability. 了解更多
  31. GDC-0339

    Catalog No. A20920
    Quick View
    Pim kinase inhibitor
    GDC-0339 is a potent, orally bioavailable and well tolerated pan-Pim kinase inhibitor, with Kis of 0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 and Pim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma. 了解更多
  32. Dafadine-A

    Catalog No. A20914
    Quick View
    DAF-9 cytochrome P450 inhibitor
    Dafadine-A, an analog of dafadine, is a novel inhibitor of DAF-9 cytochrome P450 in the nematode Caenorhabditis elegans; also inhibits the mammalian ortholog of DAF-9(CYP27A1). 了解更多
  33. Forodesine

    Catalog No. A20903
    Quick View
    PNP inhibitor
    Forodesine(BCX-1777 freebase; Immucillin-H) is an orally bioavailable PNP inhibitor with picomolar potency; induces apoptosis, mainly in T cells. 了解更多
  34. LTV-1

    Catalog No. A20901
    Quick View
    LYP inhibitor
    LTV-1 is a highly potent, cell-permeable and reversible inhibitor of lymphoid tyrosine phosphatase (LYP) (IC50 = 508 nM). 了解更多
  35. Imirestat

    Catalog No. A20868
    Quick View
    aldose reductase inhibitor
    Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes. 了解更多
  36. Voxelotor

    Catalog No. A20863
    Quick View
    HbS polymerization inhibitor
    Voxelotor (GBT 440) is an orally bioavailable sickle hemoglobin (HbS) polymerization inhibitor. 了解更多
  37. Edasalonexent

    Catalog No. A20853
    Quick View
    NF-κB inhibitor
    Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor. 了解更多
  38. AS194949

    Catalog No. A20847
    Quick View
    SHIP-2 inhibitor
    AS1949490 is a potent and selective SHIP-2 (SH2 domain-containing inositol 5?? phosphatase 2) inhibitor, with an IC50 of 620 nM. AS1949490 activated glucose metabolism via up-regulation of GLUT1 gene in L6 myotubes. 了解更多
  39. BAMB-4

    Catalog No. A20842
    Quick View
    ITPKA inhibitor
    BAMB-4(ITPKA-IN-C14) is a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A((ITPKA) with IC50 of 37 μM in ADP-Glo Assay. 了解更多
  40. Nicodicosapent

    Catalog No. A20841
    Quick View
    SREBP inhibitor
    Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1. 了解更多
  41. Niraparib hydrochloride

    Catalog No. A18018
    Quick View
    PARP1 and PARP2 inhibitor
    Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. 了解更多
  42. Edoxaban

    Catalog No. A18015
    Quick View
    factor Xa (FXa) inhibitor
    Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention. 了解更多
  43. Alectinib Hydrochloride

    Catalog No. A18000
    Quick View
    ALK inhibitor
    Alectinib Hydrochloride (CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively. 了解更多
  44. Dapagliflozin ((2S)-1,2-propanediol, hydrate)

    Catalog No. A17687
    Quick View
    SGLT2 inhibitor
    Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of drug used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine. 了解更多
  45. Apatinib

    Catalog No. A17249
    Quick View
    tyrosine kinase inhibitor
    Apatinib (YN968D1) is an orally bioavailable tyrosine kinase inhibitor, which selectively targets VEGFR-2 with an IC50 of 1 nM. 了解更多
  46. Niraparib tosylate

    Catalog No. A16618
    Quick View
    PARP1/PARP2 inhibitor
    Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. 了解更多
  47. Diethylcarbamazine citrate

    Catalog No. A16506
    Quick View
    arachidonic acid metabolism inhibitor
    Diethylcarbamazine citrate is an inhibitor of arachidonic acid metabolism in filarial microfilaria; is highly specific for several parasites and does not contain any toxic metallic elements. 了解更多
  48. 2-Deoxy-D-glucose

    Catalog No. A16478
    Quick View
    glucose metabolism inhibitor
    2-Deoxy-D-glucose is a glucose analog that acts as a competitive inhibitor of glucose metabolism, inhibiting glycolysis via its actions on hexokinase. 了解更多
  49. Talabostat

    Catalog No. A14079
    Quick View
    DPP-IV inhibitor
    Talabostat (Val-boroPro; PT100) is an orally active and nonselective dipeptidyl peptidase IV (DPP-IV) inhibitor (IC50 < 4 nM; Ki = 0.18 nM) and the first clinical inhibitor of fibroblast activation protein (FAP) (IC50 = 560 nM). 了解更多
  50. Nav1.7-IN-3

    Catalog No. A13626
    Quick View
    voltage-gated sodium channel Nav1.7 inhibitor
    Nav1.7-IN-3 is a selective, orally bioavailable voltage-gated sodium channel Nav1.7 inhibitor with an IC50 of 8 nM. Pain relief. Limited CNS penetration. 了解更多

产品 51 到 100 共 366个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置降序顺序
Rewards